Haemonetics Corp (HAE)

39.65
NYSE : Health Care
Prev Close 39.65
Day Low/High 0.00 / 0.00
52 Wk Low/High 28.15 / 43.62
Avg Volume 314.90K
Exchange NYSE
Shares Outstanding 52.50M
Market Cap 2.06B
EPS -1.10
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,200 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: ALJ, BOJA, CDK, GLOP, IRCP, KTWO, MYE, PKOH, SNHY, SPKE, TSEM Downgrades: CATM, DHT, ETM, HAE, MUX, RBA, XPER Initiations: AGLE Read on to get TheStreet Quant Ratings' detailed report:

Market Rally Rates a Meh

There is very little upside mo-mehn-tum.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,200 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: CMT, HAE, MOMO, PCYO, PIH, PPC, RVLT, SEM, SYNL, TDOC Downgrades: LAYN, PCOM, RAND, RBPAA, SPLP Initiations: FNBG Read on to get TheStreet Quant Ratings' detailed report:

Short Interest In Haemonetics Moves 15.6% Higher

The most recent short interest data has been released for the 02/28/2017 settlement date, which shows a 320,606 share increase in total short interest for Haemonetics Corp. , to 2,372,059.0, an increase of 15.63% since 01/31/2017.

Haemonetics 3rd Quarter Fiscal 2017 Earnings Release Available On Investor Relations Website

Financial release accessible online

The Medical Center Of Plano Texas Selects Haemonetics® BloodTrack® Technology

The Medical Center Of Plano Texas Selects Haemonetics® BloodTrack® Technology

Hospital joins several healthcare organizations that use the innovative technology to deliver life-saving blood transfusions to trauma patients

Haemonetics Appoints Bill Burke CFO

Haemonetics Appoints Bill Burke CFO

Invetech, Haemonetics, And Coramed Technologies Receive 2016 Good Design Award® For Development Of The TEG® 6s

Invetech, Haemonetics, And Coramed Technologies Receive 2016 Good Design Award® For Development Of The TEG® 6s

New hemostasis analysis system allows clinicians to better maintain a patient's coagulation equilibrium using unique all-in-one design

Haemonetics Honored For Delivering 'World-Class' Customer Service

Haemonetics Honored For Delivering 'World-Class' Customer Service

Receives Omega's prestigious NorthFace ScoreBoard Award(SM) for exceeding customer expectations

Haemonetics Announces CFO's Retirement

Haemonetics Announces CFO's Retirement